Status:
COMPLETED
Retorna Facial Cream in the Treatment of Facial Wrinkles
Lead Sponsor:
Catalysis SL
Conditions:
Facial Wrinkles
Eligibility:
FEMALE
20-60 years
Phase:
PHASE3
Brief Summary
The purpose of the study is to assess the efficacy of Retorna facial cream usage in the reduction or total correction of facial wrinkles. The duration of this double-blind placebo controlled phase 3 c...
Eligibility Criteria
Inclusion
- Facial wrinkles
- Signed informed consent
- Given verbal agreement on solar exposure prevention within hours of intense solar radiation (10 am - 4 pm) by the usage of physical protection methods such as umbrellas, caps and hats.
Exclusion
- Pregnancy
- Breast-feeding
- Use of steroids within 6 months.
- Patients under other experimental treatment
- Decompensated concomitant diseases
- Malignant neoplastic conditions.
- Alcoholism
- Handicap and/or psychiatric condition preventing treatment accomplishment.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT00978887
Start Date
October 1 2009
End Date
May 1 2010
Last Update
May 18 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
"Commander Manuel Fajardo Rivero" Hospital
Havana, La Habana, Cuba, 10400